Y Safety and Efficacy of Dose Escalation of Defibrotide in Hematopoietic Stem Cell Transplantation (HSCT) Recipients with Sinusoidal Obstructive Syndrome (SOS) Refractory to Standard Treatment Doses of Defibrotide

PEDIATRIC BLOOD & CANCER(2022)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要